1,625 results found

On 25 August 2017 the Supreme People's Court ("SPC") of the People's Republic of China ("PRC") promulgated the Provisions of the Supreme People's Court on Several Issues...

An organization's talent pool is an important intangible asset, as it continuously injects innovation and creates an impetus for further development while generating substantial benefits and ...

This Advisory summarizes developments in the compliance environment for life sciences companies in China in the first half of 2025, following significant developments from 2024.

If foreign companies / individuals want to entrust a Chinese lawyer to attend litigation in a Court located in China, China Civil Procedural Law requires them to sign a Power of Attorney.

China’s revised Arbitration Law came into force on 1 March 2026. Key changes include, but are not limited to: (1) the formal recognition of the legal concept of the “seat of arbitration” and clarification of its legal significance...

Cross border transfer of personal information is increasingly a necessity and becomes fundamental to modern global business operation. Multinational companies often manage employment and customer relationships...

For decades, foreign businesses have been keen to enter the Chinese market.

On 30 January 2020, the Director General of the World Health Organisation announced that the outbreak of the coronavirus (officially named Covid-19) met the criteria for a Public Health...

From 1 September 2026, dividends paid by foreign-invested enterprises to foreign individual shareholders are taxed at 20 per cent. Official commentary suggests most investors will see no net increase. For one of the most common foreign investor profiles in China, that is not the case.

In this article, we will discuss practical tips in 10 key areas for the better and effective management of outbound M&A transactions by PRC investors.

There are a number of business sectors in China such as telecommunications services, online commerce and auction in which direct foreign investment is restricted. Limits are placed on the percentage amount of foreign ownership of companies in these sectors.

自科创板于2019年3月22日正式受理申请企业以来，截至目前，已有百余家企业递交了申请。什么样的企业适合上科创板？这也是我们为客户提供相Ð

China's approach to programme trading and its regulations has evolved rapidly in recent years.

On February 4, 2026, the General Office of the National Healthcare Security Administration issued the Notice on Conducting Collective Interviews with Designated Medical Institutions for Mental Illnesses...

In this article, we follow up on our overview of going private transactions by focusing on an important but often overlooked workstream in these deals.

Nearly two decades ago, our law firm represented an American company in acquiring a large Chinese business.

On May 7, 2026, China’s National Medical Products Administration (NMPA), in conjunction with six other government agencies, issued the Management Measures for Medical Representatives (Management Measures, 医药代表管理办法), which will take effect on August 1, 2026.